Contemporary Oncology (Oct 2022)
Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score
Abstract
No abstracts available.Keywords
Contemporary Oncology (Oct 2022)